One variant per line data for interfering substance study.

<p>One variant per line data for interfering substance study.</p>

Saved in:
Bibliographic Details
Main Author: Wenshu Li (762627) (author)
Other Authors: Jeffrey A. Leibowitz (22634004) (author), Shuoguo Wang (189094) (author), Louisa Walker (22634007) (author), Chang Xu (102022) (author), Kuei-Ting Chen (22634010) (author), Alexa B. Schrock (11359638) (author), Jason Hughes (7601516) (author), Nimesh Patel (3407483) (author), Julia A. Elvin (14930571) (author), Lauren L. Ritterhouse (7553384) (author), Ethan Sokol (3548789) (author), Garrett Frampton (7374938) (author), Lucas Dennis (599740) (author), Bahar Yilmazel (22634013) (author), Brennan Decker (145811) (author)
Published: 2025
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1852014774808739840
author Wenshu Li (762627)
author2 Jeffrey A. Leibowitz (22634004)
Shuoguo Wang (189094)
Louisa Walker (22634007)
Chang Xu (102022)
Kuei-Ting Chen (22634010)
Alexa B. Schrock (11359638)
Jason Hughes (7601516)
Nimesh Patel (3407483)
Julia A. Elvin (14930571)
Lauren L. Ritterhouse (7553384)
Ethan Sokol (3548789)
Garrett Frampton (7374938)
Lucas Dennis (599740)
Bahar Yilmazel (22634013)
Brennan Decker (145811)
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author_facet Wenshu Li (762627)
Jeffrey A. Leibowitz (22634004)
Shuoguo Wang (189094)
Louisa Walker (22634007)
Chang Xu (102022)
Kuei-Ting Chen (22634010)
Alexa B. Schrock (11359638)
Jason Hughes (7601516)
Nimesh Patel (3407483)
Julia A. Elvin (14930571)
Lauren L. Ritterhouse (7553384)
Ethan Sokol (3548789)
Garrett Frampton (7374938)
Lucas Dennis (599740)
Bahar Yilmazel (22634013)
Brennan Decker (145811)
author_role author
dc.creator.none.fl_str_mv Wenshu Li (762627)
Jeffrey A. Leibowitz (22634004)
Shuoguo Wang (189094)
Louisa Walker (22634007)
Chang Xu (102022)
Kuei-Ting Chen (22634010)
Alexa B. Schrock (11359638)
Jason Hughes (7601516)
Nimesh Patel (3407483)
Julia A. Elvin (14930571)
Lauren L. Ritterhouse (7553384)
Ethan Sokol (3548789)
Garrett Frampton (7374938)
Lucas Dennis (599740)
Bahar Yilmazel (22634013)
Brennan Decker (145811)
dc.date.none.fl_str_mv 2025-11-17T18:40:08Z
dc.identifier.none.fl_str_mv 10.1371/journal.pone.0336940.s005
dc.relation.none.fl_str_mv https://figshare.com/articles/dataset/One_variant_per_line_data_for_interfering_substance_study_/30642095
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Medicine
Cell Biology
Genetics
Molecular Biology
Biotechnology
Cancer
Virology
Biological Sciences not elsewhere classified
sequencers yielded agreement
normal tissue specimens
foundationone &# 174
ensure chromosomal integrity
copy number features
negative percent agreement
negative samples showed
validation results underscore
positive percent agreement
hrr gene alterations
independent hrd biomarker
278 solid tumor
high analytical concordance
analytical validation
tumor biomarker
negative replicates
spiked samples
tumor purity
hrdsig results
targeted therapies
sister chromatid
sensitize tumors
score based
reproducibility testing
reliable assessment
reagent lots
positive rate
polymerase inhibitors
overall robustness
oscillation patterns
may benefit
low false
interfering substances
identify patients
hrr pathway
hrd signature
epigenetic mechanisms
dna scar
demonstrating 100
certified laboratory
cellular pathway
cell viability
based chemotherapy
based approach
44 %.
126 hrd
11 positive
100 hrd
dc.title.none.fl_str_mv One variant per line data for interfering substance study.
dc.type.none.fl_str_mv Dataset
info:eu-repo/semantics/publishedVersion
dataset
description <p>One variant per line data for interfering substance study.</p>
eu_rights_str_mv openAccess
id Manara_ad080277f46003cffca90cf0ff8a1206
identifier_str_mv 10.1371/journal.pone.0336940.s005
network_acronym_str Manara
network_name_str ManaraRepo
oai_identifier_str oai:figshare.com:article/30642095
publishDate 2025
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling One variant per line data for interfering substance study.Wenshu Li (762627)Jeffrey A. Leibowitz (22634004)Shuoguo Wang (189094)Louisa Walker (22634007)Chang Xu (102022)Kuei-Ting Chen (22634010)Alexa B. Schrock (11359638)Jason Hughes (7601516)Nimesh Patel (3407483)Julia A. Elvin (14930571)Lauren L. Ritterhouse (7553384)Ethan Sokol (3548789)Garrett Frampton (7374938)Lucas Dennis (599740)Bahar Yilmazel (22634013)Brennan Decker (145811)MedicineCell BiologyGeneticsMolecular BiologyBiotechnologyCancerVirologyBiological Sciences not elsewhere classifiedsequencers yielded agreementnormal tissue specimensfoundationone &# 174ensure chromosomal integritycopy number featuresnegative percent agreementnegative samples showedvalidation results underscorepositive percent agreementhrr gene alterationsindependent hrd biomarker278 solid tumorhigh analytical concordanceanalytical validationtumor biomarkernegative replicatesspiked samplestumor purityhrdsig resultstargeted therapiessister chromatidsensitize tumorsscore basedreproducibility testingreliable assessmentreagent lotspositive ratepolymerase inhibitorsoverall robustnessoscillation patternsmay benefitlow falseinterfering substancesidentify patientshrr pathwayhrd signatureepigenetic mechanismsdna scardemonstrating 100certified laboratorycellular pathwaycell viabilitybased chemotherapybased approach44 %.126 hrd11 positive100 hrd<p>One variant per line data for interfering substance study.</p>2025-11-17T18:40:08ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1371/journal.pone.0336940.s005https://figshare.com/articles/dataset/One_variant_per_line_data_for_interfering_substance_study_/30642095CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/306420952025-11-17T18:40:08Z
spellingShingle One variant per line data for interfering substance study.
Wenshu Li (762627)
Medicine
Cell Biology
Genetics
Molecular Biology
Biotechnology
Cancer
Virology
Biological Sciences not elsewhere classified
sequencers yielded agreement
normal tissue specimens
foundationone &# 174
ensure chromosomal integrity
copy number features
negative percent agreement
negative samples showed
validation results underscore
positive percent agreement
hrr gene alterations
independent hrd biomarker
278 solid tumor
high analytical concordance
analytical validation
tumor biomarker
negative replicates
spiked samples
tumor purity
hrdsig results
targeted therapies
sister chromatid
sensitize tumors
score based
reproducibility testing
reliable assessment
reagent lots
positive rate
polymerase inhibitors
overall robustness
oscillation patterns
may benefit
low false
interfering substances
identify patients
hrr pathway
hrd signature
epigenetic mechanisms
dna scar
demonstrating 100
certified laboratory
cellular pathway
cell viability
based chemotherapy
based approach
44 %.
126 hrd
11 positive
100 hrd
status_str publishedVersion
title One variant per line data for interfering substance study.
title_full One variant per line data for interfering substance study.
title_fullStr One variant per line data for interfering substance study.
title_full_unstemmed One variant per line data for interfering substance study.
title_short One variant per line data for interfering substance study.
title_sort One variant per line data for interfering substance study.
topic Medicine
Cell Biology
Genetics
Molecular Biology
Biotechnology
Cancer
Virology
Biological Sciences not elsewhere classified
sequencers yielded agreement
normal tissue specimens
foundationone &# 174
ensure chromosomal integrity
copy number features
negative percent agreement
negative samples showed
validation results underscore
positive percent agreement
hrr gene alterations
independent hrd biomarker
278 solid tumor
high analytical concordance
analytical validation
tumor biomarker
negative replicates
spiked samples
tumor purity
hrdsig results
targeted therapies
sister chromatid
sensitize tumors
score based
reproducibility testing
reliable assessment
reagent lots
positive rate
polymerase inhibitors
overall robustness
oscillation patterns
may benefit
low false
interfering substances
identify patients
hrr pathway
hrd signature
epigenetic mechanisms
dna scar
demonstrating 100
certified laboratory
cellular pathway
cell viability
based chemotherapy
based approach
44 %.
126 hrd
11 positive
100 hrd